目的:探讨慢性心力衰竭患者脑钠肽(BNP)水平与体质量指数(BMI)的关系,明确BNP水平对慢性肥胖心力衰竭患者预后评估的影响。方法:老年充血性心力衰竭患者54例(男性30例,女性24例,左室射血分数<50%),测量患者身高、体重,根据BMI将患者分为3组:对照组(BMI<24 kg·m-2)、超重组(BMI=24~27.9kg·m-2)及肥胖组(BMI≥28kg·m-2),通过免疫荧光方法测定患者血浆BNP水平,比较各组血浆BNP水平及BNP水平与BMI的相关性。结果:(1) 肥胖组患者血浆BNP水平明显低于对照组及超重组(均为P<0.01);(2) BNP与BMI之间存在负相关关系(r=-0.91,P<0.01)。结论:心力衰竭患者血浆中BNP浓度随BMI增加而降低,在应用BNP对心力衰竭患者进行心功能评价时,应同时考虑肥胖因素对其产生的影响。 |
[1] KENCHAIAH S,POCOCK S J,WANG D,et al.Body mass index and prognosis in patients with chronic heart failure:insights from the Candesartan in heart failure:assessment of reduction in mortality and morbidity (CHARM) program[J]. Circulation,2007,116(6):627-636.
[2] FONAROW G C,SRIKANTHAN P,COSTANZO M R,et al. An obesity paradox in acute heart failure:analysis of body mass index and inhospital mortality for 108 927 patients in the Acute Decompensated Heart Failure National Registry[J]. Am Heart J,2007,153(1):74-81.
[3] 毛治尉,朱春霞,黄进,等.慢性心力衰竭患者血浆精氨酸血管加压素及脑钠肽的变化[J].现代医学,2009,37(3):220-222.
[4] DICKSTEIN K,COHEN-SOLAL A.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:The task force for diagnosis and treatment of acute and chronic heart failure 2008 of European society of cardiology, developed in collaboration with the heart failure association of the ESC (HFA)and endorsed by the European Society of Intensive Care Medicine(ESICM)[J]. Eur Heart J,2008,29(19):2388-2422.
[5] 中国糖尿病防治指南编写组.肥胖病[M]//中国糖尿病防治指南.北京:北京大学医学出版社,2004:37-39.
[6] TACOY G,ACIKAOZ K,KOCAMAN S A,et al.Is there a relationship between obesity, heart rate variability and inflammatory parameters in heart failure?[J].J Cardiovasc Med (Hagerstown),2010,11(2):118-124.
[7] KLEINZ M J,DACENPORT A P.Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells[J].Regulatory Peptides,2004,118(3):119-125.
[8] DAS S R,DRAZNER M H,DRIES D L,et al.Impact of body mass and body composition on circulating levels of natriuretic peptides:results from the Dallas Heart Study[J].Circulation,2005,112(14):2163-2168.
[9] SARZANI R,DESSI-FULSHERI P,PACI V M,et al.Expression of natriuretie peptide receptors in human adipose and other tissues[J].J Endocrinol Invest,1996,19(9):581-585.
[10] SARZANI R,STRAZZULLO P,SALVI F,et al.Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity[J].Obes Res,2004,12(2):351-356.
[11] MA K K,OGAWA T,de BOLD A J.Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by proinflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase[J].J Mol Cell Cardiol,2004,36(4):505-513.
[12] 严金川,王翠平,杨萍,等.慢性心力衰竭患者体内CD40L高表达的临床意义[J].现代医学,2008,36(6):400-403.
[13] SENGENES C,BERLAN M,de GLISEZIMKI I,et al.Natriuretic peptides:a new lipolytic pathway in human adipoeytes[J].FASEB J,2000,14(10):1345-1351. |